Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial
Byrd, John C, Hillmen, Peter, Ghia, Paolo, Kater, Arnon P, Chanan-Khan, Asher, Furman, Richard R, O'Brien, Susan, Yenerel, Mustafa Nuri, Illés, Arpad, Kay, Neil, Garcia-Marco, Jose A, Mato, Anthony, Pinilla-Ibarz, Javier, Seymour, John F, Lepretre, Stephane, Stilgenbauer, Stephan, Robak, Tadeusz, Rothbaum, Wayne, Izumi, Raquel, Hamdy, Ahmed, Patel, Priti, Higgins, Kara, Sohoni, Sophia, Jurczak, Wojciech
Published in Journal of clinical oncology (01.11.2021)
Published in Journal of clinical oncology (01.11.2021)
Get full text
Journal Article
Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
Seymour, John F, Kipps, Thomas J, Eichhorst, Barbara, Hillmen, Peter, D’Rozario, James, Assouline, Sarit, Owen, Carolyn, Gerecitano, John, Robak, Tadeusz, De la Serna, Javier, Jaeger, Ulrich, Cartron, Guillaume, Montillo, Marco, Humerickhouse, Rod, Punnoose, Elizabeth A, Li, Yan, Boyer, Michelle, Humphrey, Kathryn, Mobasher, Mehrdad, Kater, Arnon P
Published in The New England journal of medicine (22.03.2018)
Published in The New England journal of medicine (22.03.2018)
Get full text
Journal Article
Fixed Duration of Venetoclax-Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease and Prolongs Survival: Post-Treatment Follow-Up of the MURANO Phase III Study
Kater, Arnon P, Seymour, John F, Hillmen, Peter, Eichhorst, Barbara, Langerak, Anton W, Owen, Carolyn, Verdugo, Maria, Wu, Jenny, Punnoose, Elizabeth A, Jiang, Yanwen, Wang, Jue, Boyer, Michelle, Humphrey, Kathryn, Mobasher, Mehrdad, Kipps, Thomas J
Published in Journal of clinical oncology (01.02.2019)
Published in Journal of clinical oncology (01.02.2019)
Get full text
Journal Article
Incidence and management of toxicity associated with ibrutinib and idelalisib: a practical approach
de Weerdt, Iris, Koopmans, Suzanne M, Kater, Arnon P, van Gelder, Michel
Published in Haematologica (Roma) (01.10.2017)
Published in Haematologica (Roma) (01.10.2017)
Get full text
Journal Article
Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial
Wang, Michael, Rule, Simon, Zinzani, Pier Luigi, Goy, Andre, Casasnovas, Olivier, Smith, Stephen D, Damaj, Gandhi, Doorduijn, Jeanette, Lamy, Thierry, Morschhauser, Franck, Panizo, Carlos, Shah, Bijal, Davies, Andrew, Eek, Richard, Dupuis, Jehan, Jacobsen, Eric, Kater, Arnon P, Le Gouill, Steven, Oberic, Lucie, Robak, Taduesz, Covey, Todd, Dua, Richa, Hamdy, Ahmed, Huang, Xin, Izumi, Raquel, Patel, Priti, Rothbaum, Wayne, Slatter, J Greg, Jurczak, Wojciech
Published in The Lancet (British edition) (17.02.2018)
Published in The Lancet (British edition) (17.02.2018)
Get full text
Journal Article
Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study
Kater, Arnon P, Wu, Jenny Qun, Kipps, Thomas, Eichhorst, Barbara, Hillmen, Peter, D'Rozario, James, Assouline, Sarit, Owen, Carolyn, Robak, Tadeusz, de la Serna, Javier, Jaeger, Ulrich, Cartron, Guillaume, Montillo, Marco, Dubois, Julie, Eldering, Eric, Mellink, Clemens, Van Der Kevie-Kersemaekers, Anne-Marie, Kim, Su Young, Chyla, Brenda, Punnoose, Elizabeth, Bolen, Christopher R, Assaf, Zoe June, Jiang, Yanwen, Wang, Jue, Lefebure, Marcus, Boyer, Michelle, Humphrey, Kathryn, Seymour, John F
Published in Journal of clinical oncology (01.12.2020)
Published in Journal of clinical oncology (01.12.2020)
Get full text
Journal Article
Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab
Seymour, John F., Kipps, Thomas J., Eichhorst, Barbara F., D'Rozario, James, Owen, Carolyn J., Assouline, Sarit, Lamanna, Nicole, Robak, Tadeusz, de la Serna, Javier, Jaeger, Ulrich, Cartron, Guillaume, Montillo, Marco, Mellink, Clemens, Chyla, Brenda, Panchal, Anesh, Lu, Tong, Wu, Jenny Q., Jiang, Yanwen, Lefebure, Marcus, Boyer, Michelle, Kater, Arnon P.
Published in Blood (25.08.2022)
Published in Blood (25.08.2022)
Get full text
Journal Article
T-cell dysfunction in chronic lymphocytic leukemia from an epigenetic perspective
Peters, Fleur S, Strefford, Jonathan C, Eldering, Eric, Kater, Arnon P
Published in Haematologica (Roma) (01.05.2021)
Published in Haematologica (Roma) (01.05.2021)
Get full text
Journal Article
Chronic lymphocytic leukemia cells are active participants in microenvironmental cross-talk
van Attekum, Martijn Ha, Eldering, Eric, Kater, Arnon P
Published in Haematologica (Roma) (01.09.2017)
Published in Haematologica (Roma) (01.09.2017)
Get full text
Journal Article
Engaging Cytotoxic T and NK Cells for Immunotherapy in Chronic Lymphocytic Leukemia
Hofland, Tom, Eldering, Eric, Kater, Arnon P, Tonino, Sanne H
Published in International journal of molecular sciences (03.09.2019)
Published in International journal of molecular sciences (03.09.2019)
Get full text
Journal Article
Impact of Minimal Residual Disease on Progression-Free Survival Outcomes After Fixed-Duration Ibrutinib-Venetoclax Versus Chlorambucil-Obinutuzumab in the GLOW Study
Munir, Talha, Moreno, Carol, Owen, Carolyn, Follows, George, Benjamini, Ohad, Janssens, Ann, Levin, Mark-David, Osterborg, Anders, Robak, Tadeusz, Simkovic, Martin, Stevens, Don, Voloshin, Sergey, Vorobyev, Vladimir, Yagci, Munci, Ysebaert, Loic, Qi, Keqin, Qi, Qianya, Parisi, Lori, Srinivasan, Srimathi, Schuier, Natasha, Baeten, Kurt, Howes, Angela, Caces, Donne Bennett, Niemann, Carsten U, Kater, Arnon P
Published in Journal of clinical oncology (20.07.2023)
Published in Journal of clinical oncology (20.07.2023)
Get full text
Journal Article
Resistance to ABT-199 induced by microenvironmental signals in chronic lymphocytic leukemia can be counteracted by CD20 antibodies or kinase inhibitors
Thijssen, Rachel, Slinger, Erik, Weller, Katinka, Geest, Christian R, Beaumont, Tim, van Oers, Marinus H J, Kater, Arnon P, Eldering, Eric
Published in Haematologica (Roma) (01.08.2015)
Published in Haematologica (Roma) (01.08.2015)
Get full text
Journal Article
Electron transport chain and mTOR inhibition synergistically decrease CD40 signaling and counteract venetoclax resistance in chronic lymphocytic leukemia
Chen, Zhenghao, Cretenet, Gaspard, Carnazzo, Valeria, Simon-Molas, Helga, Kater, Arnon P, Windt, Gerritje J W van der, Eldering, Eric
Published in Haematologica (Roma) (01.01.2024)
Published in Haematologica (Roma) (01.01.2024)
Get full text
Journal Article
JAK–STAT signalling shapes the NF‐κB response in CLL towards venetoclax sensitivity or resistance via Bcl‐XL
Haselager, Marco V., Thijssen, Rachel, Bax, Danique, Both, Demi, De Boer, Francien, Mackay, Simon, Dubois, Julie, Mellink, Clemens, Kater, Arnon P., Eldering, Eric
Published in Molecular oncology (01.06.2023)
Published in Molecular oncology (01.06.2023)
Get full text
Journal Article
miR-34a as part of the resistance network in chronic lymphocytic leukemia
Zenz, Thorsten, Mohr, Julia, Eldering, Eric, Kater, Arnon P., Bühler, Andreas, Kienle, Dirk, Winkler, Dirk, Dürig, Jan, van Oers, Marinus H.J., Mertens, Daniel, Döhner, Hartmut, Stilgenbauer, Stephan
Published in Blood (16.04.2009)
Published in Blood (16.04.2009)
Get full text
Journal Article
Final results and overall survival data from a phase II study of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma, including those with poor prognostic factors
Le Gouill, Steven, Długosz-Danecka, Monika, Rule, Simon, Zinzani, Pier Luigi, Goy, Andre, Smith, Stephen D, Doorduijn, Jeanette K, Panizo, Carlos, Shah, Bijal D, Davies, Andrew J, Eek, Richard, Jacobsen, Eric, Kater, Arnon P, Robak, Tadeusz, Jain, Preetesh, Calvo, Roser, Tao, Lin, Wang, Michael
Published in Haematologica (Roma) (01.01.2024)
Published in Haematologica (Roma) (01.01.2024)
Get full text
Journal Article
Inhibition of casein kinase 2 sensitizes mantle cell lymphoma to venetoclax through MCL-1 downregulation
Thus, Yvonne J, De Rooij, Martin F M, Swier, Nathalie, Beijersbergen, Roderick L, Guikema, Jeroen E J, Kersten, Marie-José, Eldering, Eric, Pals, Steven T, Kater, Arnon P, Spaargaren, Marcel
Published in Haematologica (Roma) (01.03.2023)
Published in Haematologica (Roma) (01.03.2023)
Get full text
Journal Article
Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemia
Thijssen, Rachel, ter Burg, Johanna, Garrick, Brett, van Bochove, Gregor G.W., Brown, Jennifer R., Fernandes, Stacey M., Rodríguez, María Solé, Michot, Jean-Marie, Hallek, Michael, Eichhorst, Barbara, Reinhardt, Hans Christian, Bendell, Johanna, Derks, Ingrid A.M., van Kampen, Roel J.W., Hege, Kristen, Kersten, Marie José, Trowe, Torsten, Filvaroff, Ellen H., Eldering, Eric, Kater, Arnon P.
Published in Blood (28.07.2016)
Published in Blood (28.07.2016)
Get full text
Journal Article